90 related articles for article (PubMed ID: 19782464)
1. Disulfiram/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines.
Guo X; Xu B; Pandey S; Goessl E; Brown J; Armesilla AL; Darling JL; Wang W
Cancer Lett; 2010 Apr; 290(1):104-13. PubMed ID: 19782464
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties.
Yip NC; Fombon IS; Liu P; Brown S; Kannappan V; Armesilla AL; Xu B; Cassidy J; Darling JL; Wang W
Br J Cancer; 2011 May; 104(10):1564-74. PubMed ID: 21487404
[TBL] [Abstract][Full Text] [Related]
3. The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells.
Rae C; Tesson M; Babich JW; Boyd M; Sorensen A; Mairs RJ
J Nucl Med; 2013 Jun; 54(6):953-60. PubMed ID: 23616582
[TBL] [Abstract][Full Text] [Related]
4. Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo.
Liu P; Wang Z; Brown S; Kannappan V; Tawari PE; Jiang W; Irache JM; Tang JZ; Armesilla AL; Darling JL; Tang X; Wang W
Oncotarget; 2014 Sep; 5(17):7471-85. PubMed ID: 25277186
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
[TBL] [Abstract][Full Text] [Related]
6. Use of the disulfiram/copper complex for breast cancer chemoprevention in MMTV-erbB2 transgenic mice.
Yang Y; Deng Q; Feng X; Sun J
Mol Med Rep; 2015 Jul; 12(1):746-52. PubMed ID: 25738885
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer.
Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR
Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405
[TBL] [Abstract][Full Text] [Related]
8. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
Triscott J; Rose Pambid M; Dunn SE
Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells.
Wiggins HL; Wymant JM; Solfa F; Hiscox SE; Taylor KM; Westwell AD; Jones AT
Biochem Pharmacol; 2015 Feb; 93(3):332-42. PubMed ID: 25557293
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: copper unlocks therapeutic potential of disulfiram.
Thoma C
Nat Rev Urol; 2014 Dec; 11(12):664. PubMed ID: 25366297
[No Abstract] [Full Text] [Related]
11. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.
O'Brien A; Barber JE; Reid S; Niknejad N; Dimitroulakos J
Anticancer Res; 2012 Jul; 32(7):2679-88. PubMed ID: 22753726
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.
Xu B; Shi P; Fombon IS; Zhang Y; Huang F; Wang W; Zhou S
Blood Cells Mol Dis; 2011 Dec; 47(4):264-9. PubMed ID: 21911303
[TBL] [Abstract][Full Text] [Related]
13. Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome.
Cvek B
Curr Cancer Drug Targets; 2011 Mar; 11(3):332-7. PubMed ID: 21247389
[TBL] [Abstract][Full Text] [Related]
14. Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram/Cu2+ complex to breast and colon cancer cells.
Navrátilová J; Hankeová T; Beneš P; Šmarda J
Chemotherapy; 2013; 59(2):112-20. PubMed ID: 24051574
[TBL] [Abstract][Full Text] [Related]
15. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells.
Liu P; Kumar IS; Brown S; Kannappan V; Tawari PE; Tang JZ; Jiang W; Armesilla AL; Darling JL; Wang W
Br J Cancer; 2013 Oct; 109(7):1876-85. PubMed ID: 24008666
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.
Liu P; Brown S; Goktug T; Channathodiyil P; Kannappan V; Hugnot JP; Guichet PO; Bian X; Armesilla AL; Darling JL; Wang W
Br J Cancer; 2012 Oct; 107(9):1488-97. PubMed ID: 23033007
[TBL] [Abstract][Full Text] [Related]
17. Activity of aspirin analogues and vanillin in a human colorectal cancer cell line.
Deb J; Dibra H; Shan S; Rajan S; Manneh J; Kankipati CS; Perry CJ; Nicholl ID
Oncol Rep; 2011 Sep; 26(3):557-65. PubMed ID: 21617874
[TBL] [Abstract][Full Text] [Related]
18. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo.
Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G
Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113
[TBL] [Abstract][Full Text] [Related]
19. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
